Benevolentai

BenevolentAI was founded in 2013 to improve quality of life and protect our way of life through technology. That belief has guided everything we've built. Today, there's more scientific knowledge being created than any human can process. We build AI systems that help humanity make sense of it - technology that can read, reason across, and explain the world's biomedical knowledge. Our approach proved its value when our AI identified baricitinib as a potential Covid-19 treatment within 48 hours, a drug that went on to save lives globally. That wasn't about replacing scientists but extending what they could achieve. Now we're making that capability accessible to the broader life sciences ecosystem through Qor, our strategic decision intelligence platform for biotech leaders. Technology in service of life. BenevolentAI is headquartered in London, UK.